The FDA has tapped Codenomicon Defensics to help it establish a "cybersecurity laboratory" that would be used to screen medical devices for software glitches and other vulnerabilities before they are released on the market. The move follows recent FDA guidelines calling for increased industry vigilance on cybersecurity threats to medical devices.

Related Summaries